14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $2.47 Thursday, 25th Apr 2024 AKBA stock ended at $1.33. This is 2.92% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.05% from a day low at $1.31 to a day high of $1.35.
90 days $1.31 $2.47
52 weeks $0.780 $2.47

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Jan 08, 2024 $1.49 $1.58 $1.43 $1.57 2 531 838
Jan 05, 2024 $1.53 $1.59 $1.46 $1.48 2 397 782
Jan 04, 2024 $1.38 $1.52 $1.36 $1.52 4 463 067
Jan 03, 2024 $1.29 $1.38 $1.27 $1.37 2 877 368
Jan 02, 2024 $1.22 $1.30 $1.21 $1.27 1 293 900
Dec 29, 2023 $1.30 $1.31 $1.22 $1.24 2 121 596
Dec 28, 2023 $1.18 $1.31 $1.18 $1.28 3 815 519
Dec 27, 2023 $1.21 $1.22 $1.16 $1.20 1 473 042
Dec 26, 2023 $1.19 $1.24 $1.18 $1.19 1 158 006
Dec 22, 2023 $1.22 $1.22 $1.16 $1.19 1 477 317
Dec 21, 2023 $1.22 $1.24 $1.20 $1.20 1 575 966
Dec 20, 2023 $1.20 $1.23 $1.17 $1.20 1 162 967
Dec 19, 2023 $1.19 $1.21 $1.15 $1.19 1 457 396
Dec 18, 2023 $1.16 $1.20 $1.14 $1.15 1 057 438
Dec 15, 2023 $1.15 $1.16 $1.11 $1.15 1 244 748
Dec 14, 2023 $1.14 $1.16 $1.11 $1.13 1 291 072
Dec 13, 2023 $1.09 $1.13 $1.07 $1.11 1 031 719
Dec 12, 2023 $1.11 $1.13 $1.05 $1.07 812 155
Dec 11, 2023 $1.11 $1.15 $1.10 $1.11 778 860
Dec 08, 2023 $1.17 $1.18 $1.12 $1.13 869 618
Dec 07, 2023 $1.19 $1.20 $1.15 $1.17 904 429
Dec 06, 2023 $1.14 $1.17 $1.11 $1.16 953 535
Dec 05, 2023 $1.14 $1.18 $1.11 $1.12 1 061 364
Dec 04, 2023 $1.09 $1.18 $1.07 $1.15 2 056 003
Dec 01, 2023 $1.06 $1.09 $1.02 $1.07 1 191 922
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT